About
Susan M. Shortreed, PhD, is affiliated with Kaiser Permanente Washington Health Research Institute in Seattle. Her publications from 2015 to 2024 focus on patient care topics including suicide risk assessment, depression (MDD), psychotic disorders, and schizophrenia/schizoaffective disorders. Her work addresses clinical issues such as clozapine use in psychotic disorders, antidepressant adherence, and suicide risk prediction using machine learning. She has frequently collaborated with Gregory E. Simon, Karen J. Coleman, Arne Beck, Rebecca C. Rossom, and Eric Johnson.
